Low performance of a SARS-CoV-2 point-of-care lateral flow immunoassay in symptomatic children during the pandemic

OBJECTIVE: to evaluate the accuracy of an antibody point-of-care lateral flow immunoassay (LFI - Wondfo Biotech Co., Guangzhou, China) in a pediatric population. METHODS: children and adolescents (2 months to 18 years) with signs and symptoms suggestive of acute SARS-CoV-2 infection were prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Scotta, Marcelo Comerlato, David, Caroline Nespolo de, Varela, Fernanda Hammes, Sartor, Ivaine Tais Sauthier, Polese-Bonatto, Márcia, Fernandes, Ingrid Rodrigues, Zavaglia, Gabriela Oliveira, Ferreira, Charles Francisco, Kern, Luciane Beatriz, Santos, Amanda Paz, Krauzer, João Ronaldo Mafalda, Pitrez, Paulo Márcio, Almeida, Walquiria Aparecida Ferreira de, Porto, Victor Bertollo Gomes, Stein, Renato T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173459/
https://www.ncbi.nlm.nih.gov/pubmed/34153236
http://dx.doi.org/10.1016/j.jped.2021.04.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173459/
https://www.ncbi.nlm.nih.gov/pubmed/34153236
http://dx.doi.org/10.1016/j.jped.2021.04.010

Ejemplares similares